REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $415,000 | -29.5% | 4,120 | -1.0% | 0.00% | -33.3% |
| Q2 2021 | $589,000 | +28.9% | 4,163 | -9.2% | 0.00% | +50.0% |
| Q1 2021 | $457,000 | -36.6% | 4,587 | -21.4% | 0.00% | -33.3% |
| Q4 2020 | $721,000 | +28.3% | 5,834 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $562,000 | -41.5% | 5,777 | -6.1% | 0.00% | -40.0% |
| Q2 2020 | $960,000 | +104.7% | 6,152 | +89.3% | 0.01% | +66.7% |
| Q1 2020 | $469,000 | -34.5% | 3,250 | -7.1% | 0.00% | 0.0% |
| Q4 2019 | $716,000 | +154.8% | 3,500 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $281,000 | -15.1% | 3,500 | -0.3% | 0.00% | -50.0% |
| Q2 2019 | $331,000 | +18.6% | 3,509 | +7.7% | 0.00% | +100.0% |
| Q1 2019 | $279,000 | +36.8% | 3,259 | +30.4% | 0.00% | 0.0% |
| Q3 2018 | $204,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |